Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danish Out-of-Hospital Cardiac Arrest study (DANOHCA)
2021-005876-21Phase 3Active
- Sponsor
- Rigshospitalet
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexamethasone and olanzapine in cardiac arrest (SCA), sponsored by Rigshospitalet. Primary endpoint: All-cause mortality at 90 days following cardiac arrest (dexamethasone protective effect). Started Dec 2021; status: active.
02
Drugs
dexamethasoneolanzapine
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2021-005876-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005876-21.